FDA 483 - The Mentholatum Company - June 17, 2021
Discuss this record with AI
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.
An FDA inspection of The Mentholatum Company in Orchard Park, NY, from June 15-17, 2021, revealed significant deficiencies in manufacturing practices. Observations included failures to follow written procedures for raw material testing, inadequate cleaning and maintenance of equipment, and plumbing defects posing contamination risks. Additionally, the firm was cited for a repeat deficiency regarding the delayed submission of an adverse event report for a nonprescription drug.
ID · fd2a2e74-28ba-405b-8c31-9280b8195291